perkinelmer address

PerkinElmer was founded by Charles Elmer and Richard Perkin in 1937.  The company operated originally as an optical design and consulting company and transitioned to the analytical instruments business in 1944.

In 1999 the company merged with EG&G Inc. The new company kept the PerkinElmer name.

Today PerkinElmer designs, produces, and markets equipment used by researchers to identify and treat diseases as well as analyze food products and identify contaminants in air, water, and soil.

PerkinElmer trades publicly on the New York Stock Exchange under the ticker symbol RVTY, is a member of the S&P 500, is #920 in the Fortune 1000, has 16,700 employees, and had $2.24 billion in revenue in 2014.

In March 2021, PerkinElmer announced that the company had completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec) and in May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million and Immunodiagnostic Systems Holdings PLC for $155 million. 

In May 2023, the company sold off part of its Food and Enterprise Services division, along with its name. PerkinElmer has rebranded itself as Revvity. 

Revvity maintains a corporate office in Waltham, Massachusetts.

PerkinElmer/Revvity

PerkinElmer was founded by Charles Elmer and Richard Perkin in 1937.  The company operated originally as an optical design and consulting company and transitioned to the analytical instruments business in 1944.

In 1999 the company merged with EG&G Inc. The new company kept the PerkinElmer name.

History

Today PerkinElmer designs, produces, and markets equipment used by researchers to identify and treat diseases as well as analyze food products and identify contaminants in air, water, and soil.

PerkinElmer trades publicly on the New York Stock Exchange under the ticker symbol RVTY, is a member of the S&P 500, is #920 in the Fortune 1000, has 16,700 employees, and had $2.24 billion in revenue in 2014.

In March 2021, PerkinElmer announced that the company had completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec) and in May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million and Immunodiagnostic Systems Holdings PLC for $155 million. 

In May 2023, the company sold off part of its Food and Enterprise Services division, along with its name. PerkinElmer has rebranded itself as Revvity. 

Revvity maintains a corporate office in Waltham, Massachusetts.